{"docstore/metadata": {"df50a38a-d423-4676-b758-166627823210": {"doc_hash": "abbe1510ca87fc46714586f5c767bf7ce1d7fd592587f5a1f338a03cddd1185a"}, "e427a8c0-9fdf-40b6-abcf-770458edd3b7": {"doc_hash": "78abb3685b973da5e1fd128dd6a9e0c9e39ddc7b03f3ef0070ce25dccc173e5e"}, "325c2088-2d2b-45e1-8a12-e7bfad3f95d9": {"doc_hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2"}, "f00d5479-fb5c-463c-a5da-71e64cd105d8": {"doc_hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4"}, "38aea7b8-ec53-4afe-97f1-266c1ab77f6e": {"doc_hash": "aa35cda100f7dd457c088366fb464a6067f691b8c48008efa7e7e53df3cbc6b5", "ref_doc_id": "df50a38a-d423-4676-b758-166627823210"}, "7b64702e-62ca-410e-a508-f34f7cc1654d": {"doc_hash": "94ca186eb9048fe886b6531b54fab12e14b4baf90d52136d494540a9058f5955", "ref_doc_id": "df50a38a-d423-4676-b758-166627823210"}, "8b1ab4d3-5136-4f21-84d6-e39ea33b849e": {"doc_hash": "9c967bdbbe9a14cdb6ff3e996fcf6d83d97903e1cdd378898d556a4dff653ff3", "ref_doc_id": "df50a38a-d423-4676-b758-166627823210"}, "eab954c8-8198-46ef-8ce9-1ea35e17658f": {"doc_hash": "05467560b459e282e2c025bca3dd82744964ca078dfedfbd51224e641c44b954", "ref_doc_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7"}, "617d443d-320b-4317-91d5-7872e7fa821b": {"doc_hash": "20d304086b30f22de880fb874137e1e75f949a58f94cfce58a738c881ceb99ab", "ref_doc_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7"}, "33a1bede-da25-48fa-a9e3-d078e8c9dd27": {"doc_hash": "88afa4d8a6ea5799e86ac8032d080fbda40e9414b2ad871cd2a703d2f3a9d3e1", "ref_doc_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7"}, "3688d930-c38a-4a89-a40d-5a8a59c72eab": {"doc_hash": "bfb4250b9e6672fb9ec81d43a5f1d2002b80b4da6d96a593b6d03b6826df8b63", "ref_doc_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7"}, "60fe1b3f-a700-47b0-8d4f-f7ff04eb6036": {"doc_hash": "1ac9666b68c10bbd3a1ee8a3eb5e2637e21dc6dde19e217e10b85697e58cb7b9", "ref_doc_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9"}, "5d97ff48-b6ef-4180-a565-faf428c02505": {"doc_hash": "7b52795876bc84a27158cfc6ae4e693d7e484ae67b87580df9d0cce72e34f01f", "ref_doc_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9"}, "2fa35169-7135-47fd-b902-2ee970265fc6": {"doc_hash": "254818440453c0808091fa8566388ba01435c2740da03bfa6de3dd5d9273c2ad", "ref_doc_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9"}, "a3094d6a-159e-400c-8e3b-87c7c22176c7": {"doc_hash": "54be6094a870a4ac2adedb876de668f0458f4763c79786e678c26e1f953e3453", "ref_doc_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9"}, "d5506b81-4c75-4a04-b799-d36216d08cce": {"doc_hash": "a58d51e20bcc12b8832f0bcab48e02559289864182f1ea92eae012256c692f73", "ref_doc_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9"}, "24915b2a-acea-480f-b7aa-df7369c0a99a": {"doc_hash": "ab5bbb18558f8b9d72c8c3a6a0fcf70c0e634183ede90b7d7fa984cda1b92780", "ref_doc_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8"}, "1162f5ec-3bce-41de-a9ab-19781e1d7feb": {"doc_hash": "e2ff4a9c75bd94a9327a8b162ef79eb8477ced6e01e511ee23cbe352d8072e55", "ref_doc_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8"}, "43681aa7-38de-4e02-a3d8-d3e98584b8ba": {"doc_hash": "42e7098d054f98cf4dcf08c6d984c75bb5daf7e6453ac3badbe26c5915899df3", "ref_doc_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8"}, "6ab45ba9-3368-42b6-9948-04c0d4a1ede4": {"doc_hash": "bb6783ab60f225f28cbcf46c4c98a3aa25060c5117c5bf6dc167dc6bd6a954a6", "ref_doc_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8"}, "ed77e1d4-bac0-491b-a97d-4ca43ceffff2": {"doc_hash": "d667b41284f6aefbd911515341872f5303f9ff826f71b0fe553ae0117446ca5d", "ref_doc_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8"}}, "docstore/data": {"38aea7b8-ec53-4afe-97f1-266c1ab77f6e": {"__data__": {"id_": "38aea7b8-ec53-4afe-97f1-266c1ab77f6e", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "df50a38a-d423-4676-b758-166627823210", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "abbe1510ca87fc46714586f5c767bf7ce1d7fd592587f5a1f338a03cddd1185a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b64702e-62ca-410e-a508-f34f7cc1654d", "node_type": "1", "metadata": {}, "hash": "9d67e34e803e2ecee7de7356fc3a4ce50189e245d8559150fb2b849cc0fa80ac", "class_name": "RelatedNodeInfo"}}, "text": "Mediterr J Hematol Infect Dis 2014; 6 ; Open Journal System  \n  MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES  \nwww.mjhid.org  ISSN 2035 -3006  \n \n \nOriginal  Article   \n \nComparison of Antimicrobial Sensitivity to Older and Newer Quinolones versus \nPiperacillin -Tazobactam, Cefepime and Meropenem in Febrile Patients with Cancer \nin two Referral Pediatric Centers in Tehran, Iran  \n \nAR. Nateghian\u00b9, JL . Robinson\u00b2, P . Vosough\u00b3,  M. Navidinia4, M. Malekan4, A. Mehrvar, B . Sobouti3, P. Bahadoran5 \nand Z. Gholinejad4 \n \n1 Department of Pediatrics, Iran University of Medical Sciences, Tehran, Iran  \n\u00b2 Department of Pediatrics , University of Alberta and Stollery  Children's Hospital. Edmonton, Canada  \n3 Mahak Hospital and Rehabilitation Complex, Tehran, Iran  \n4 Pediatric Infections Research Center, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, \nTehran,Iran  \n5 Aliasghar  Children\u2019s Hospital, Iran University of Medical Sciences, Tehran, Iran  \n \nCorrespondance  to: Joan Robinson . 3-588D ECHA , 11405 -87Ave , Edmonton, Ab Canada T6G 1C9 . Fax: 1-888-\n790-1176 . E-mail: jr3@ualberta.ca   \n \nCompeting interests: The author s have declared th at no competing interests exist .", "start_char_idx": 0, "end_char_idx": 1230, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7b64702e-62ca-410e-a508-f34f7cc1654d": {"__data__": {"id_": "7b64702e-62ca-410e-a508-f34f7cc1654d", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "df50a38a-d423-4676-b758-166627823210", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "abbe1510ca87fc46714586f5c767bf7ce1d7fd592587f5a1f338a03cddd1185a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38aea7b8-ec53-4afe-97f1-266c1ab77f6e", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "aa35cda100f7dd457c088366fb464a6067f691b8c48008efa7e7e53df3cbc6b5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b1ab4d3-5136-4f21-84d6-e39ea33b849e", "node_type": "1", "metadata": {}, "hash": "2ced492f328f980e46d3ecad91e7e90d12994b0ca46239bd73952d5d5379c4f2", "class_name": "RelatedNodeInfo"}}, "text": "Fax: 1-888-\n790-1176 . E-mail: jr3@ualberta.ca   \n \nCompeting interests: The author s have declared th at no competing interests exist . \n \nPublished:  July 1, 2014 \nReceived:  February 11, 2014 \nAccepted:  May 30, 2014 \nCitation : Medit err J Hemat ol Infect Dis 20 14, 6(1): e2014045, DOI: 10.4084/MJHID.201 4.045 \nThis article is available from: http://www.mjhid.org/article/view/12948   \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License \n(http://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, \nprovided the original work is properly cited.   \n  \nAbstract .  \nBackground . Infection in pediatric cancer patients has become a concerning problem due to \nincreasing antimicrobial resistance. The goal of this study was to determine the antimicrobial \nresistance patterns of blood isolates from pediatric oncology patients in Iran to d etermine if there \nwas significant resistance to quinolones  \nMethods . Children with cancer who were admitted with or developed fever during admission to \nAliasghar Children\u2019s Hospital or Mahak Hospitals July 2009 through June 2011 were eligible for \nenrollmen t. Two blood cultures were obtained.  Antimicrobial sensitivity test was performed for \nciprofloxacin, moxifloxacin, gatifloxacin, meropenem, cefepime, and piperacillin -tazobactam on \nisolates from children who were bacteremic.  \nResults .", "start_char_idx": 1094, "end_char_idx": 2555, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8b1ab4d3-5136-4f21-84d6-e39ea33b849e": {"__data__": {"id_": "8b1ab4d3-5136-4f21-84d6-e39ea33b849e", "embedding": null, "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "df50a38a-d423-4676-b758-166627823210", "node_type": "4", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "abbe1510ca87fc46714586f5c767bf7ce1d7fd592587f5a1f338a03cddd1185a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b64702e-62ca-410e-a508-f34f7cc1654d", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94ca186eb9048fe886b6531b54fab12e14b4baf90d52136d494540a9058f5955", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eab954c8-8198-46ef-8ce9-1ea35e17658f", "node_type": "1", "metadata": {}, "hash": "02723ca63c18bf1ec2536df01a2b0186bfe9319d97742b4ec1053deee576896a", "class_name": "RelatedNodeInfo"}}, "text": "Results . Blood cultures were p ositive for 38 episodes in 169 enrolled children but 9 episodes were \nexcluded as blood cultures were thought to be contaminated,  yielding a bacteremia rate of 29/160 \n(18%). The mean age of children and the stage of malignancy did not differ between those w ith and \nwithout bacteremia. Meropenem was the most likely antibiotic to cover isolates (97%) with \ncefepime having the lowest coverage rate (21%). Quinolone coverage ranged from 63% to 76%.  \nConclusion . Quinolones may not be suitable for use as empiric therapy in febrile pediatric oncology \npatients in Iran.", "start_char_idx": 2546, "end_char_idx": 3150, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eab954c8-8198-46ef-8ce9-1ea35e17658f": {"__data__": {"id_": "eab954c8-8198-46ef-8ce9-1ea35e17658f", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "78abb3685b973da5e1fd128dd6a9e0c9e39ddc7b03f3ef0070ce25dccc173e5e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b1ab4d3-5136-4f21-84d6-e39ea33b849e", "node_type": "1", "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "9c967bdbbe9a14cdb6ff3e996fcf6d83d97903e1cdd378898d556a4dff653ff3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "617d443d-320b-4317-91d5-7872e7fa821b", "node_type": "1", "metadata": {}, "hash": "a926b7476c07784e4b3a75f3d6c0a330058b4fa8bca085a6dfc010620c1fcf67", "class_name": "RelatedNodeInfo"}}, "text": "Mediterr J Hematol Infect Dis 2 014; 6: Open Journal System   \n Introduction.  Infectious diseases are common life \nthreatening complications in patients with cancer, \nresulting in repeated admissions with considerable \ninterruption of treatment for the underlying \nmalignancy.1 Although the mortality rate for infectious \ndiseases has been decreasing over recent decades, most \nchildren with febrile neutropenia ar e treated as \ninpatients with long durations of admission.2 \nRecently, there are reports of successful outpatient \nmanagement of febrile neutropenia in children with \nmalignancies with oral antibiotics (typically \nquinolones).3 However,  there is a concerning in crease \nin the rate of antimicrobial resistance both in developed \nand developing countries, including quinolone \nresistance in Escherichia coli  and Klebsiella \npneumoniae . Therefore, the predicted efficacy of \nquinolones for invasive bacterial infections in ch ildren \nwith malignancies can be informative as these drugs \nare used in this setting despite not yet being approved \nin children.3 \nAliasghar Children\u2019s Hospital (an educational \nhospital affiliated with the Tehran University of \nMedical Sciences) and Mahak Hos pital (a subspecialty \nnon-profit center for children with cancer) are referral \npediatric oncology centers in Tehran.", "start_char_idx": 0, "end_char_idx": 1324, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "617d443d-320b-4317-91d5-7872e7fa821b": {"__data__": {"id_": "617d443d-320b-4317-91d5-7872e7fa821b", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "78abb3685b973da5e1fd128dd6a9e0c9e39ddc7b03f3ef0070ce25dccc173e5e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eab954c8-8198-46ef-8ce9-1ea35e17658f", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "05467560b459e282e2c025bca3dd82744964ca078dfedfbd51224e641c44b954", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "33a1bede-da25-48fa-a9e3-d078e8c9dd27", "node_type": "1", "metadata": {}, "hash": "9398165b8e6f0d7982894325795b151bedd1a64b461c4e19b09ab605c88a4a30", "class_name": "RelatedNodeInfo"}}, "text": "Almost all febrile \npediatric patients with cancer (with or without \nneutropenia) are admitted rather than treated as \noutpatients as there is  no consensus on when and how \nto use risk assessments for selecting patients for \noutpatient management.4 \nThe primary objective of this study was to \ndetermine the in -vitro susceptibility for blood culture \nisolates in these hospitals to older and newer \nquino lones and to compare this with the susceptibilities \nto current candidates for intravenous monotherapy in \nthis population.  \n \nMaterials and Methods . All children with any cancer \nirrespective of their stage of disease (including those \nwho had finished chemothe rapy or relapsed) who were \nadmitted with fever or developed fever in Aliasghar \nChildren\u2019s Hospital or Mahak Hospitals from July \n2009 through June 2011 were eligible for enrollment in \nthis descriptive prospective study. The same child \ncould be enrolled more  than once in the study. \nInformed consent was obtained from parents.  \nFever was defined as a single episode of \ntemperature above 38.5 degrees C or at least two \nepisodes of 38 degrees C one hour apart. For each \nfebrile patient, two blood cultures were  collec ted \nsimultaneously before starting or changing the \nantibiotic therapy.  Of these blood cultures, one was \nsent to  the hospital laboratory and processed by the \nstandard procedure and the other was sent to  BACTEC \nthe Pediatric Infectious Diseases Research Center located in Mofid Children\u2019s Hospital and processed by \nBACTEC technology to improve the sensitivity. \nStandard methods were used for identification of \norganisms.", "start_char_idx": 1325, "end_char_idx": 2952, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "33a1bede-da25-48fa-a9e3-d078e8c9dd27": {"__data__": {"id_": "33a1bede-da25-48fa-a9e3-d078e8c9dd27", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "78abb3685b973da5e1fd128dd6a9e0c9e39ddc7b03f3ef0070ce25dccc173e5e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "617d443d-320b-4317-91d5-7872e7fa821b", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "20d304086b30f22de880fb874137e1e75f949a58f94cfce58a738c881ceb99ab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3688d930-c38a-4a89-a40d-5a8a59c72eab", "node_type": "1", "metadata": {}, "hash": "a0b4438af766be251817314babeb97d0e509edd3c0d836ee86322ddd0bb93479", "class_name": "RelatedNodeInfo"}}, "text": "Standard methods were used for identification of \norganisms.  Children who had positive blood culture s \nfor common skin contaminants were considered to be \nbacteremic only if both samples were positive for the \nsame microorganism.  Antimicrobial sensitivity test was \nperformed for ciprofloxacin, moxifloxacin, \ngatifloxacin, meropenem, cefepime, and piperacillin -\ntazobactam according to Clinical and Laboratory \nStandards Institute (CLSI) methods using the standard \ndisk diffusion method from MAST Co (Mast Co, \nMerseyside, UK). A questionnaire was completed for \neach patient on admission and data was analyzed by \nSPSS s oftware version -16 using appropriate statistical \nmethods.  \nData are presented as numbers and proportions. \nContinuous variables are presented as mean and \nstandard deviation.  \n \nResults . There were 173 febrile episodes during the \nperiod of study. Parental conse nt was not obtained for \n4 of these episodes. Blood cultures were positive for 38 \nof the remaining 169 episodes but 9 episodes were \nexcluded from further analysis as only a single blood \nculture was positive for a common skin contaminant, \nyielding a proven b acteremia rate of 29/160 ([18%). \nAll 9 suspected contaminated blood cultures were from \nBACTEC alone. For the 29 episodes of bacteremia, \nboth blood cultures were positive in 14 episodes and \nBACTEC alone in 15 episodes.  Ninety -one of these \n160 cases were mal e (57%). The mean age of enrolled \npatients was 82 months (SD=54.4).", "start_char_idx": 2892, "end_char_idx": 4382, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3688d930-c38a-4a89-a40d-5a8a59c72eab": {"__data__": {"id_": "3688d930-c38a-4a89-a40d-5a8a59c72eab", "embedding": null, "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e427a8c0-9fdf-40b6-abcf-770458edd3b7", "node_type": "4", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "78abb3685b973da5e1fd128dd6a9e0c9e39ddc7b03f3ef0070ce25dccc173e5e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "33a1bede-da25-48fa-a9e3-d078e8c9dd27", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "88afa4d8a6ea5799e86ac8032d080fbda40e9414b2ad871cd2a703d2f3a9d3e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "60fe1b3f-a700-47b0-8d4f-f7ff04eb6036", "node_type": "1", "metadata": {}, "hash": "3b146d442c606b68a0d79599be3969423fe6c5111e3f8a9653e3aca1f4ad3cc0", "class_name": "RelatedNodeInfo"}}, "text": "Ninety -one of these \n160 cases were mal e (57%). The mean age of enrolled \npatients was 82 months (SD=54.4). The mean age of \ncases with bacteremia was 71.5 months (SD=55.6) and \nfor those with negative blood cultures or contaminated \nblood cultures was 84.3 months (SD=57.8) (P value \n=0.27).   \nThree enrolled children had two episodes of \nbacteremia during different admissions. These were not \nthought to be relapses or recurrences as two of the \nchildren had different organisms each time and the \nthird child had the same organism but with different \nsuscept ibilities.  \nThe 160 children had 19 different types of \nmalignancies ( Table 1 ). The types of malignancies in \nenrolled patients with and without bacteremia are \nshown in Table 1  (P value=0.002). Bacteremia with \nfever was especially common with acute myeloid \nleukemia (6 of 16 episodes; 37%). There was no \nsignificant difference in stage of malignancy between \nthose with and without bacteremia (P value=0.14).  \nThe organisms causing bacteremia are shown in \nTable 2  with coagulase negative staphylococci causing \n10 of the 29 cases (34%).The coverage rate was highest \nfor meropenem (97%) with cefepime having the lowest", "start_char_idx": 4273, "end_char_idx": 5468, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "60fe1b3f-a700-47b0-8d4f-f7ff04eb6036": {"__data__": {"id_": "60fe1b3f-a700-47b0-8d4f-f7ff04eb6036", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3688d930-c38a-4a89-a40d-5a8a59c72eab", "node_type": "1", "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "bfb4250b9e6672fb9ec81d43a5f1d2002b80b4da6d96a593b6d03b6826df8b63", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d97ff48-b6ef-4180-a565-faf428c02505", "node_type": "1", "metadata": {}, "hash": "d9c5bcfedca8ee0389243384c026ab79da1461a3c8d11ee38d2b2188f1704c40", "class_name": "RelatedNodeInfo"}}, "text": "Mediterr J Hematol Infect Dis 2 014; 6: Open Journal System   \n Table 1.  Presence or absence of bacteremia in 160 episodes of \nfever in children with different malignancies  \nMalignancy  Group  \nTotal  Bacteremia  No bacteremia  \n  ALL  14 (17%)  69 (83%)  83 \nAML  6(37%)  10(63%)  16 \nNeuroblastoma  1(33%)  2(67%)  3 \nNon Hodgkin\u2019s  \nlymphoma  1(50%)  1(50%)  2 \nTeratoma  1(100%)  0 1 \nBurkitt\u2019s lymphoma  1(25%)  3(75%)  4 \nPNET  1(25%)  3(75%)  4 \nWilm\u2019s tumor  2(29%)  5(71%)  7 \nGlioma  1(50%)  1(50)  2 \nOsteosarcoma  0 1(100%)  1 \nRetinoblastoma  1(13%)  7(87%)  8 \nRhabdomyosarcoma  0 12(100%)  12 \nGerm cell tumor  0 3(100%)  3 \nHodgkin\u2019s lymphoma  0 4(100%)  4 \nHistiocytosis  0 1(100%)  1 \nMedulloblastoma  0 5(100%)  5 \nRenal cell carcinoma  0 1(100%)  1", "start_char_idx": 0, "end_char_idx": 770, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5d97ff48-b6ef-4180-a565-faf428c02505": {"__data__": {"id_": "5d97ff48-b6ef-4180-a565-faf428c02505", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "60fe1b3f-a700-47b0-8d4f-f7ff04eb6036", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "1ac9666b68c10bbd3a1ee8a3eb5e2637e21dc6dde19e217e10b85697e58cb7b9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2fa35169-7135-47fd-b902-2ee970265fc6", "node_type": "1", "metadata": {}, "hash": "346da879d85e8835acfa082ea2e6817df0341bf3d28deb88ca58ecce5e79327d", "class_name": "RelatedNodeInfo"}}, "text": "Histiocytosis  0 1(100%)  1 \nMedulloblastoma  0 5(100%)  5 \nRenal cell carcinoma  0 1(100%)  1 \nEwing\u2019s sarcoma  0 2(100%)  2 \nNasopharyngeal \ncarcinoma  0 1(100%)  1 \nTotal  29(18%)  131(82%)  160 \nAML: acute myelogenous leukemia; ALL: acute lymphoblastic \nleukemia; PNET: primitive neuroectodermal tumor.  \n coverage rate (21%). Overall susceptibility rates for the \nthree quinolones were very similar to each other, \nranging from 63% to 76% ( Table 2). \n \nDiscussion . Meropenem had the highest rate of in -vitro \ncoverage for organisms isolated from bacteremic \nchildren with malignancies in Iran.  In contrast, \ncefepime susceptibility was only about 21%, a \ndramatic change from a previous study in the same \npopulation hospitals in which susceptibility was over \n80%.5 Only about 70% of the isolated organisms were \nsusceptible to quinolones with the sample  size being \ntoo small to compare ciprofloxacin to newer \nquinolones. Vital gaps in quinolone coverage included \nStaphylococcus aureus  and Klebsiella species.", "start_char_idx": 676, "end_char_idx": 1700, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2fa35169-7135-47fd-b902-2ee970265fc6": {"__data__": {"id_": "2fa35169-7135-47fd-b902-2ee970265fc6", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d97ff48-b6ef-4180-a565-faf428c02505", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "7b52795876bc84a27158cfc6ae4e693d7e484ae67b87580df9d0cce72e34f01f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3094d6a-159e-400c-8e3b-87c7c22176c7", "node_type": "1", "metadata": {}, "hash": "05e0f03e9a8c31151c00c289f684f0c306f904de23e409f03eccdf68e3b9aa73", "class_name": "RelatedNodeInfo"}}, "text": "Vital gaps in quinolone coverage included \nStaphylococcus aureus  and Klebsiella species.   \nIn a 2003 study in adults in the United States with \nmalignancies, moxifloxacin had good coverage fo r \ngram negative organisms except for Pseudomonas  \nspecies for which it was inferior to ciprofloxacin and \nlevofloxacin.6 In total, 78% of gram positive and 64% \nof gram negatives were susceptible to moxifloxacin. \nThe same group published a study in 2006, show ing \nthat gatifloxacin offered good coverage for all but \nmethicillin -resistant S. aureus , and Pseudomonas and \nAcinetobacter  species.7 In total, 83% of gram positive \nand 64% of gram negatives were susceptible to \ngatifloxacin.8 \nTable 2 .", "start_char_idx": 1611, "end_char_idx": 2311, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a3094d6a-159e-400c-8e3b-87c7c22176c7": {"__data__": {"id_": "a3094d6a-159e-400c-8e3b-87c7c22176c7", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2fa35169-7135-47fd-b902-2ee970265fc6", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "254818440453c0808091fa8566388ba01435c2740da03bfa6de3dd5d9273c2ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5506b81-4c75-4a04-b799-d36216d08cce", "node_type": "1", "metadata": {}, "hash": "47f26152c708d3ca9f13cb3a7a1dbd213fc5b0229d786384c2fff4e904a4647b", "class_name": "RelatedNodeInfo"}}, "text": "Susceptibility rates for organisms causing bacteremia in children with malignancies (N=29)(%)  \nOrganism  ciprofloxacin  moxifloxacin  gatifloxacin  meropenem  cefepime  piperacillin -\ntazobactam  \n  Streptococcus pneumoniae3 NA 3 (100%)  3 (100%)  3 (100%)  2 (67%)  NA \nCoagulase negative \nstaphylococcus10 8 (80%)  8 (80%)  9 (90%)  10 (100%)  2 (20%)  9 (90%)  \nEscherichia coli4 3 (75%)  NA 3 (75%)  4 (100%)  1 (25%)  4 (100%)  \nStaphylococcus.aureus3 1 (33%)  1 (33%)  1 (33%)  3 (100%)  1 (33%)  1 (33%)  \nPseudomonas aeruginosa1 1 (100%)  1 (100%)  1 (100%)  1 (100%)  0 0 \nCitrobacter freundii1 1 (100%)  NA 1 (100%)  1 (100%)  0 1 (100%)  \nStreptococcus viridans group2 NA 2 (100%)  2 (100%)  2 (100%)  0 2 (100%)  \nEnterococcus.", "start_char_idx": 2312, "end_char_idx": 3052, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d5506b81-4c75-4a04-b799-d36216d08cce": {"__data__": {"id_": "d5506b81-4c75-4a04-b799-d36216d08cce", "embedding": null, "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "325c2088-2d2b-45e1-8a12-e7bfad3f95d9", "node_type": "4", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "50e201002d74e981c74d5e4bb6730014a26c40b6cc61e364bfbbfc7d4492b4b2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3094d6a-159e-400c-8e3b-87c7c22176c7", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "54be6094a870a4ac2adedb876de668f0458f4763c79786e678c26e1f953e3453", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "24915b2a-acea-480f-b7aa-df7369c0a99a", "node_type": "1", "metadata": {}, "hash": "196170826785cc1951963066b9b9c039402bbac19b9185e772faa23e7a1d0b17", "class_name": "RelatedNodeInfo"}}, "text": "faecalis1 0 0 0 1 (100%)  0 1 (100%)  \nEnterobacter aerogenes1 1 (100%)  NA 1 (100%)  1 (100%)  0 1 (100%)  \nKlebsiella pneumoniae3 0 NA 1 (33%)  2 (67%)  0 1 (33%)  \nTotal susceptibility  15/24 (63%)  15/20 (75%)  22/29 (76%)  28/29 (97%)  6/29 (21%)  20/26 (77%)  \nNA - not available as break -point not established by Clinical and Laboratory Standards Institute (CLSI)  \n \nInternational guidelines for management of children \nwith malignancies and febrile neutropenia were \npublished in 2012.9 They describe six validated \nschemes for identifying children at low risk for serious \ninfection with it not being clear which scheme \nfunctions best. The guidelines report that oral \nantibiotics (often quinolones) appear to be equivalent \nto intravenous  antibiotics for empiric therapy in low -\nrisk children. In a recent meta -analysis specifically on the role of quinolones in children with febrile \nneutropenia, 10 studies (740 episodes of febrile \nneutropenia, all considered to be low -risk for poor \noutcomes) were included.3 Using varying definitions, \ntreatment success was obtained in 83% of those on \nquinolone monotherapy with there being no infection -\nrelated mortality. This success rate appeared to be \nhigher than that obtained with the usual intravenous \noption s. However, it is important to recognize that", "start_char_idx": 3052, "end_char_idx": 4375, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "24915b2a-acea-480f-b7aa-df7369c0a99a": {"__data__": {"id_": "24915b2a-acea-480f-b7aa-df7369c0a99a", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5506b81-4c75-4a04-b799-d36216d08cce", "node_type": "1", "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "a58d51e20bcc12b8832f0bcab48e02559289864182f1ea92eae012256c692f73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1162f5ec-3bce-41de-a9ab-19781e1d7feb", "node_type": "1", "metadata": {}, "hash": "57be1d0dfa1caf0601d33fb5cef460d7742c07465df875088fc0513f2f3630c5", "class_name": "RelatedNodeInfo"}}, "text": "Mediterr J Hematol Infect Dis 2 014; 6: Open Journal System   \n these studies were performed in an era when quinolone \nresistance was less common than in the current study. \nIn the absence of outcome data, it is difficult to predict \nwhat would have happened had all low risk p atients in \nthe current study been started on quinolones, but the \nhigh rate of in -vitro resistance is concerning.  \nThe major limitation of the current study is that only \nin-vitro data rather than clinical outcome data was \navailable. Clinical and Laboratory S tandards Institute  \nstandards do not yet exist for all antibiotics in this \nstudy for  some of the bacteria isolated . Patients did not \nhave to be neutropenic to be enrolled, and those who \nwere neutropenic were not further classified as low -risk \nversus high -risk for poor outcomes. It can be difficult \nto distinguish bacteremia from contaminated blood \ncultures. Processing one blood culture by BACTEC \ntechnology appeared to increase both the number of \ncontaminated blood cultures and the number of true \npositives.  \n \nConclusions . Although quinolones appeared to be a \ngood option for children with febrile neutropenia in \nother countries, one would want to be cautious given \nthe apparent high rate of resistance in Iran.", "start_char_idx": 0, "end_char_idx": 1276, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1162f5ec-3bce-41de-a9ab-19781e1d7feb": {"__data__": {"id_": "1162f5ec-3bce-41de-a9ab-19781e1d7feb", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "24915b2a-acea-480f-b7aa-df7369c0a99a", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "ab5bbb18558f8b9d72c8c3a6a0fcf70c0e634183ede90b7d7fa984cda1b92780", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "43681aa7-38de-4e02-a3d8-d3e98584b8ba", "node_type": "1", "metadata": {}, "hash": "fc2d726deb2fcf9150d7376f9a6303d3e432c672b3de44e3c1fa9d2174fc0491", "class_name": "RelatedNodeInfo"}}, "text": "Conclusions . Although quinolones appeared to be a \ngood option for children with febrile neutropenia in \nother countries, one would want to be cautious given \nthe apparent high rate of resistance in Iran. Patients who are bacteremic with pathogens of low viru lence \nsuch as coagulase negative staphylococci or \nenterococcus are likely to survive even if empiric \nantibiotics do not cover that organism, but the same is \nnot true for E. coli  or Klebsiella  species, both of which \ndemonstrated significant quinolone resist ance is the \ncurrent study.  Given the rapid emergence of multi -\nresistant gram negatives, it is imperative that rates of \nquinolone resistance be followed closely in oncology \ncenters where febrile neutropenia is being managed \nwith this class of drug.  \n \nAcknowl edgments . We would like to remember Dr. \nParvaneh Vosough, a great teacher of pediatric \noncology in Iran whose efforts for Iranian children \nwith malignancies cannot be forgotten. She passed \naway before this study was published. We kindly \nappreciate Dr. Bahr am Darbandi, Dr. Shahla Ansari, \nDr. Maryam Golparvar, Dr. Maryam Hoseini, and Dr \nTahereh Naimi for their cooperation in data collection. \nThis study was supported and funded by The Pediatric \nInfections Research Center at Mofid Children\u2019s \nHospital, Shahid Be heshti University of Medical \nSciences.  \n \nReferences:  \n1.", "start_char_idx": 1071, "end_char_idx": 2448, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "43681aa7-38de-4e02-a3d8-d3e98584b8ba": {"__data__": {"id_": "43681aa7-38de-4e02-a3d8-d3e98584b8ba", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1162f5ec-3bce-41de-a9ab-19781e1d7feb", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "e2ff4a9c75bd94a9327a8b162ef79eb8477ced6e01e511ee23cbe352d8072e55", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ab45ba9-3368-42b6-9948-04c0d4a1ede4", "node_type": "1", "metadata": {}, "hash": "9b93ef61a48cea4db09a80f7d2326089aa43b5f840651cdd52f1131e3583ab33", "class_name": "RelatedNodeInfo"}}, "text": "This study was supported and funded by The Pediatric \nInfections Research Center at Mofid Children\u2019s \nHospital, Shahid Be heshti University of Medical \nSciences.  \n \nReferences:  \n1. Walsh TS, Roilides E, Groll A, Gonzales C, Pizzo  P. Infectious \ncomplications in pediatric cancer patients. In. Principles and \npractice of pediatric oncology, Edited by Pizzo PA, Poplack DG, \nPhiladelphia: Lippincott - Williams and Wilkins; 2006: 1270 -1320.  \n2. Basu SK, Fernandez ID, Fischer SG, Asselin BL, L yman GH. \nLength of stay and mortality associated with febrile neutropenia \namong children with cancer. J Clin Oncol 2005; 23: 7958 -7966. \nhttp://dx.doi.org/10.1200/JCO.2005.01.6378     PMid:16258096      \n3. Sung L, Manji A, Beyene J, Dupuis LL, Alexander S, Phillips R, \nLehrnbecher T. Fluoroquinolones in children with fever and \nneutropenia. Pediatr Infect Dis J 2012; 31:431 -435. \nhttp://dx.doi.o rg/10.1097/INF.0b013e318245ab48     \nPMid:22189521      \n4. Brack A, Bodmer N, Simon A, Leibundgut K, Kuhne T, Niggli FK, \nAmmann RA.", "start_char_idx": 2266, "end_char_idx": 3301, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6ab45ba9-3368-42b6-9948-04c0d4a1ede4": {"__data__": {"id_": "6ab45ba9-3368-42b6-9948-04c0d4a1ede4", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "43681aa7-38de-4e02-a3d8-d3e98584b8ba", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "42e7098d054f98cf4dcf08c6d984c75bb5daf7e6453ac3badbe26c5915899df3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed77e1d4-bac0-491b-a97d-4ca43ceffff2", "node_type": "1", "metadata": {}, "hash": "0babca23b5805611dcd40011bf7f9774b0e9090c03498f5d68e1430ca190050c", "class_name": "RelatedNodeInfo"}}, "text": "Brack A, Bodmer N, Simon A, Leibundgut K, Kuhne T, Niggli FK, \nAmmann RA. First -day step -down to oral outpatient treatment \nversus continued standard treatment in children with cancer and \nlow-risk fever i n neutropenia. A randomized controlled trial within \nthe multicenter SPOG 2003 FN study. Pediatr Blood Cancer 2012; \n59: 423 -430. http://dx.doi.org/10.1002/pbc.24076     \nPMid:22271702      \n5. Nateghian AR, Voso ugh P, Ramezanian E, Ziaii AR, Mirsaiidi K, \nSedighi M, Ziaii M: Bloodstream infections in febrile children with \nvarious cancers; a 10 -year experience at a single Iranian institution. In Proceedings of the Annual Meeting of the European Society of \nPediatric  Infectious Disease: 2 -4 May 2007: Porto,Portugal.   \nPMid:17443472      \n6. Rolston K, Frisbee -Hune S, LeBlanc B, Steeter H, Ho DH. In vitro \nantimicrobial activity of moxifloxacin compared to other \nquinolones against recent clinical bacterial isolates from \nhospitalized and community based cancer patients. Diagn \nMicrobiol Infect Dis 2003; 44: 441 -449. \nhttp://dx.doi.org/10.1016/S0732 -8893(03)00115 -9   \n7. Rolston K, Yadegarnia D, Kontoyaiannis D, Raad Il , Ho DH.", "start_char_idx": 3228, "end_char_idx": 4387, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ed77e1d4-bac0-491b-a97d-4ca43ceffff2": {"__data__": {"id_": "ed77e1d4-bac0-491b-a97d-4ca43ceffff2", "embedding": null, "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f00d5479-fb5c-463c-a5da-71e64cd105d8", "node_type": "4", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "94c21aa08487cecc2dc9435d1470e5ecfef4fe98ddfdb61deb4c9c707cb46ce4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ab45ba9-3368-42b6-9948-04c0d4a1ede4", "node_type": "1", "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}, "hash": "bb6783ab60f225f28cbcf46c4c98a3aa25060c5117c5bf6dc167dc6bd6a954a6", "class_name": "RelatedNodeInfo"}}, "text": "Rolston K, Yadegarnia D, Kontoyaiannis D, Raad Il , Ho DH. The \nspectrum of gram positive blood stream infections in patients with \nhematologic malignancies. Int J Infect Dis 2006; 10: 223 -230. \nhttp://dx.doi.org/10.1016/j.ijid.2005.05.007     PMid: 16439177      \n8. Petrilli A, Carlesse F, Periera C. Oral Gatifloxacin in outpatient \ntreatment of children with cancer fever and neutropenia. Pediatr \nBlood Cancer 2007; 49: 682 -686. \nhttp://dx.doi.org/10.1002/ pbc.21124     PMid:17253640      \n9. Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, \nFisher B, et al Guideline for the management of fever and \nneutropenia in children with cancer and/or undergoing \nhematopoietic stem -cell tr ansplantation. J Clin Oncol. 2012; 30: \n4427 -4438. http://dx.doi.org/10.1200/JCO.2012.42.7161     \nPMid:22987086", "start_char_idx": 4329, "end_char_idx": 5148, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"df50a38a-d423-4676-b758-166627823210": {"node_ids": ["38aea7b8-ec53-4afe-97f1-266c1ab77f6e", "7b64702e-62ca-410e-a508-f34f7cc1654d", "8b1ab4d3-5136-4f21-84d6-e39ea33b849e"], "metadata": {"page_label": "1", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}}, "e427a8c0-9fdf-40b6-abcf-770458edd3b7": {"node_ids": ["eab954c8-8198-46ef-8ce9-1ea35e17658f", "617d443d-320b-4317-91d5-7872e7fa821b", "33a1bede-da25-48fa-a9e3-d078e8c9dd27", "3688d930-c38a-4a89-a40d-5a8a59c72eab"], "metadata": {"page_label": "2", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}}, "325c2088-2d2b-45e1-8a12-e7bfad3f95d9": {"node_ids": ["60fe1b3f-a700-47b0-8d4f-f7ff04eb6036", "5d97ff48-b6ef-4180-a565-faf428c02505", "2fa35169-7135-47fd-b902-2ee970265fc6", "a3094d6a-159e-400c-8e3b-87c7c22176c7", "d5506b81-4c75-4a04-b799-d36216d08cce"], "metadata": {"page_label": "3", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}}, "f00d5479-fb5c-463c-a5da-71e64cd105d8": {"node_ids": ["24915b2a-acea-480f-b7aa-df7369c0a99a", "1162f5ec-3bce-41de-a9ab-19781e1d7feb", "43681aa7-38de-4e02-a3d8-d3e98584b8ba", "6ab45ba9-3368-42b6-9948-04c0d4a1ede4", "ed77e1d4-bac0-491b-a97d-4ca43ceffff2"], "metadata": {"page_label": "4", "file_name": "D:/Lab/PKU\u9879\u76ee\u5408\u96c6/Medical-Literature-Benchmark/documents/25045453/25045453.pdf", "file_path": "documents\\25045453\\25045453.pdf", "file_type": "application/pdf", "file_size": 322346, "creation_date": "2024-04-12", "last_modified_date": "2024-04-12"}}}}